Skip to main content
. 2020 Mar;9(3):1787–1794. doi: 10.21037/tcr.2020.02.26

Table 2. Univariate analysis of progress-free survival (PFS) in 155 patients with gastric gastrointestinal stromal tumors (GISTs).

Index Cases Recurrence, metastasis or death, n (%) P value
Yes No
Age (years) 0.313
   <60 years 81 13 (16.0) 68 (84.0)
   ≥60 years 74 17 (23.0) 57 (77.0)
Gender 0.836
   Male 93 19 (20.4) 74 (79.6)
   Female 62 11 (17.7) 51 (82.3)
Size (cm) 0.005
   <5 49 3 (6.1) 46 (93.9)
   5–10 78 17 (21.8) 61 (78.2)
   >10 28 10 (35.7) 18 (64.3)
Shape 0.004
   Round/oval 69 6 (8.7) 61 (91.3)
   Lobulated/irregular 86 24 (27.9) 62 (72.1)
Necrosis or cystic degeneration 0.003
   Yes 99 26 (26.3) 73 (73.7)
   No 56 4 (7.1) 52 (92.9)
Margin <0.001
   Defined/smooth 126 12 (9.5) 114 (90.5)
   0 rough/Ill-defined 29 18 (62.1) 11 (37.9)
Growth pattern <0.001
   Endophytic 132 17 (12.9) 115 (87.1)
   Exophytic 23 13 (56.5) 10 (43.5)
Enhancement pattern 0.016
   Homogeneous 37 2 (5.4) 35 (94.6)
   Heterogeneous 118 28 (23.7) 90 (76.3)
Mitotic rate 0.015
   <5 83 10 (12.0) 73 (88.0)
   ≥5 72 20 (27.8) 52 (72.2)
Ki-67 index 0.023
   <10 123 19 (15.4) 104 (84.6)
   ≥10 32 11 (34.4) 21 (65.6)